Delivery Order SPE2DB20D2014-SPE2DB25FA83X
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,727,588 units of Valganciclovir 450 mg tablets. The $21,045.78 firm-fixed-price delivery order has a completion date of December 17, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,948.63 firm fixed-price delivery order is for the supply of 4558106928 valganciclovir HCL 50 mg/ml medication. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 15, 2022. No set-aside was used for this open competition contract. AmerisourceBergen holds a $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $3,331.00 to AmerisourceBergen Drug Corp for Valganciclovir HCL 50 mg/ml in an 88 ml formulation, with an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the awardee's facility in Conshohocken, Pennsylvania. The order represents a single delivery task under AmerisourceBergen's larger relationship with the federal government's...
- The Defense Logistics Agency issued a $3,681.03 delivery order to Amerisourcebergen Drug Corp on April 1, 2026, for Valganciclovir 450 mg tablets (60-count). The order is a call against the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026, which supplies pharmaceutical products and medical commodities to military healthcare programs globally. Place of performance is Conshohocken, PA. The order is firm fixed price with an...
- The Defense Logistics Agency awarded a $2,354.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 450 mg valganciclovir tablets. Under this order, Amerisourcebergen will deliver 60 tablets of the specified medication to a location in Conshohocken, Pennsylvania by August 17, 2023 to support the Department of Defense's medical supply needs. As a top pharmaceutical supplier, Amerisourcebergen routinely fulfills delivery orders under the Defense Logistics...
- The Defense Logistics Agency awarded a $300,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 450 mg valganciclovir tablets. Under this order, Amerisourcebergen will deliver 60 tablets to a facility in Conshohocken, Pennsylvania by July 19, 2023 in support of the Department of Defense's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen frequently supports the Defense Logistics Agency's mission of providing critical medicines and medical...
- This federal contract award, valued at $14,984.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VALCYTE 450 MG TABLET 60S, with an ultimate completion date of November 23, 2022. The contract is not designated as a set-aside and is a firm fixed-price type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4566142810 VALACYCLOVIR 1GM 90S, a pharmaceutical product. The fixed-price delivery order, valued at $14,750.77, has an ultimate completion date of November 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999...
- This federal contract award, valued at $1,446.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valacyclovir HCL 1 gram tablets in 90-count packages. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 22, 2024. The award was not designated under any set-aside program, indicating open...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,024.62 firm-fixed-price delivery order is for Valacyclovir HCL 1 gram tablets in quantities of 90. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FA83XDelivery Order
This federal contract award, valued at $4,629.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valganciclovir 450 mg tablets, a medication used in the treatment of cytomegalovirus infections. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 21, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 1/17/25 |